PCSK9 Inhibition After Heart Transplantation

Condition:   Vasculopathy Interventions:   Biological: alirocumab;   Biological: placebo Sponsors:   Stanford University;   National Heart, Lung, and Blood Institute (NHLBI) Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials